NEUMOSUIN
NEUMOSUIN
Authorised
- Actinobacillus pleuropneumoniae, Serotype 5, Inactivated
- Actinobacillus pleuropneumoniae, Serotype 4, Inactivated
- Actinobacillus pleuropneumoniae, Serotype 2, Inactivated
Product identification
Medicine name:
НЕВМОСУИН
NEUMOSUIN
Active substance:
- Actinobacillus pleuropneumoniae, Serotype 5, Inactivated
- Actinobacillus pleuropneumoniae, Serotype 4, Inactivated
- Actinobacillus pleuropneumoniae, Serotype 2, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Actinobacillus pleuropneumoniae, Serotype 5, Inactivated4.00billion organisms2.00millilitre(s)
-
Actinobacillus pleuropneumoniae, Serotype 4, Inactivated4.00billion organisms2.00millilitre(s)
-
Actinobacillus pleuropneumoniae, Serotype 2, Inactivated4.00billion organisms2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AB07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Package description:
- Available only in Bulgarian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra, S.A.
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-1574-07.06.2011
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 17/05/2022
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 17/05/2022
How useful was this page?: